---
title: "Double Medical: Double Medical Commerce intends to acquire all equity of Junlaixin for 47.2704 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/232933273.md"
description: "Double Medical announced that its major shareholder, Double Business Tong, intends to acquire all the equity of Xiamen Junlaixin Investment Co., Ltd. for 47.2704 million yuan. Upon completion, it will hold 100% of Junlaixin's equity, and the indirect equity stake in Shiaide will increase from 9% to 23.5%. This move is based on the company's long-term strategic planning, aimed at controlling risks and enhancing Shiaide's management and market sales capabilities, promoting its long-term stable development"
datetime: "2025-03-24T09:05:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/232933273.md)
  - [en](https://longbridge.com/en/news/232933273.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/232933273.md)
---

# Double Medical: Double Medical Commerce intends to acquire all equity of Junlaixin for 47.2704 million yuan

According to the Zhitong Finance APP, Double Medical (002901.SZ) announced that Xiamen Junlaixin Investment Co., Ltd. ("Junlaixin") is a shareholder of its 51% owned subsidiary Shide (Xiamen) Medical Equipment Co., Ltd. ("Shide"). The company's major shareholder Guangxi Double Business Communication Venture Capital Co., Ltd. ("Double Business Communication") intends to sign a "Share Transfer Agreement" with Junlaixin shareholders Liao Baoyong and Wu Qiaoli, whereby Double Business Communication plans to use its own funds of 47.2704 million yuan to acquire all the equity held by Junlaixin shareholders Liao Baoyong and Wu Qiaoli. Upon completion of this equity transfer, Double Business Communication will hold 100% of Junlaixin's equity, and its indirect equity stake in Shide will change from 9% to 23.5%.

This transaction is based on the company's long-term strategic planning and operational development considerations. Against the backdrop of ongoing policy impacts in the medical device industry, Shide's products may face the possibility of national procurement or secondary procurement. The major shareholder Double Business Communication's stake in Shide is beneficial for the company to control risks. Additionally, Mr. Lin Zhixiong, the actual controller of Double Business Communication, has been engaged in the medical device industry for many years and possesses rich management experience and specialized industry insight, which can provide significant assistance to Shide's management and market sales efforts, helping to enhance Shide's sustainable operational capabilities and overall competitive advantages. The increase in personal shareholding ratio by founder Mr. Lin Zhixiong is conducive to further empowering him, increasing employee confidence in Shide's long-term development, and promoting Shide's long-term stable growth

### Related Stocks

- [002901.CN](https://longbridge.com/en/quote/002901.CN.md)

## Related News & Research

- [Asker Healthcare Group buys Baltic medtech distributor Ambercell Solutions](https://longbridge.com/en/news/296306272.md)
- [11:19 ETEon Appoints Matthew Lungren, MD, MPH, to Board of Directors](https://longbridge.com/en/news/296375443.md)
- [Wolters Kluwer analysis shows US subpoena volumes hit seven-year high](https://longbridge.com/en/news/296378082.md)
- [11:06 ETEndurance Named to Inc. 5000 for 11th Time, Continuing National Growth](https://longbridge.com/en/news/296124358.md)
- [Flexdeal chair Alberto Amaral buys EUR 150,000 in shares](https://longbridge.com/en/news/296250174.md)